注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   精选抗体   >   Anti-IL-19 Reference Antibody (Cheng Kung U. patent anti-IL-19)   

Anti-IL-19 Reference Antibody (Cheng Kung U. patent anti-IL-19)

     
  • 0 - Anti-IL-19 Reference Antibody (Cheng Kung U. patent anti-IL-19) APR11542
    Anti-IL-19 Reference Antibody (Cheng Kung U. patent anti-IL-19) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
  • 0 - Anti-IL-19 Reference Antibody (Cheng Kung U. patent anti-IL-19) APR11542
    The purity of Anti-IL-19 Reference Antibody (Cheng Kung U. patent anti-IL-19) is 96.43%, determined by SEC-HPLC.
  • 0 - Anti-IL-19 Reference Antibody (Cheng Kung U. patent anti-IL-19) APR11542
    Immobilized hu-IL-19(Q9UHD0)-his, It’s target at 2 µg/mL can bind Cheng Kung U. patent anti-IL-19, EC50= 0.05822 µg/mL.
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession Q9UHD0
Reactivity Human
Clonality Monoclonal
Isotype mIgG1-TW-DD
Calculated MW 20452 Da
Additional Information
Target/Specificity IL-19
Expression system CHO

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Name IL19
Synonyms ZMDA1
Function Cytokine that functions as an anti-inflammatory and proangiogenic factor (PubMed:34932373). Polarizes adaptive immunity to an anti-inflammatory phenotype through induction of T-helper 2 responses by both down-regulation of IFN-gamma and up-regulation of IL4 and IL13 (PubMed:16365913). Produced by osteocytes, stimulates granulopoiesis and neutrophil formation (By similarity). Exerts its biological effect through a receptor complex consisting of a heterodimer of IL20RA and IL20RB (PubMed:12351624). In turn, activates the Janus kinase (JAK) and signal transducer and activator of transcription (STAT) pathway, and importantly, STAT3 (PubMed:11564763).
Cellular Location Secreted.
Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价